Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 10024
TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509092(US11071788, Example M4 | S-(1-{2-[2-({(2S)-2-Amino...)
Affinity DataIC50: 0.271nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509099(US11071788, Example M12 | 4-{[(1R)-2-({2-[(3-Amino...)
Affinity DataIC50: 0.446nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509093(US11071788, Example M5 | (3R,7S)-7-Amino-17-{[(2R)...)
Affinity DataIC50: 0.457nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509097(US11071788, Example M10 | (2R,28R)-28-Amino-2-[({2...)
Affinity DataIC50: 0.470nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509095(US11071788, Example M7 | S-(2-{[2-({(2S)-2-Amino-4...)
Affinity DataIC50: 0.621nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509109(US11071788, Example M22 | (2R,27R)-27-Amino-2-[({2...)
Affinity DataIC50: 0.827nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509113(US11071788, Example M26 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 0.944nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509102(US11071788, Example M15 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 0.964nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509096(US11071788, Example M9 | N-(3-Aminopropyl)-N-{(1R)...)
Affinity DataIC50: 1.07nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509098(US11071788, Example M11 | S-{2-[(3-Aminopropyl){(1...)
Affinity DataIC50: 1.11nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509110(US11071788, Example M23 | N-{(2S)-2-Amino-4-[{(1R)...)
Affinity DataIC50: 1.26nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509103(US11071788, Example M16 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 1.48nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509100(US11071788, Example M13 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 1.5nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509107(US11071788, Example M20 | (1R,4R,27R,33R)-1-Amino-...)
Affinity DataIC50: 1.5nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509091(US11071788, Example M3 | 4-[(2-{[(2R)-2-({(2S)-2-A...)
Affinity DataIC50: 1.52nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509094(US11071788, Example M6 | 2-{[(2R)-2-Amino-2-carbox...)
Affinity DataIC50: 1.78nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509089(US11071788, Example M1 | S-[1-(2-{[2-({(2S)-2-Amin...)
Affinity DataIC50: 2.01nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509114(US11071788, Example M27 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 2.03nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509101(US11071788, Example M14 | 4-[(2-{[2-({(2S)-2-Amino...)
Affinity DataIC50: 2.16nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509108(US11071788, Example M21 | (2R,24S,27R)-27-Amino-2-...)
Affinity DataIC50: 2.31nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509090(US11071788, Example M2 | 4-[(2-{[2-({(2S)-2-Amino-...)
Affinity DataIC50: 2.45nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509106(US11071788, Example M19 | N6 (N-{(2S)-2-Amino-4-[{...)
Affinity DataIC50: 2.58nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509111(US11071788, Example M24 | N-{(2S)-2-Amino-4-[{(1R)...)
Affinity DataIC50: 2.90nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509112(US11071788, Example M25 | N-{(2S)-2-Amino-4-[{(1R)...)
Affinity DataIC50: 2.91nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509104(US11071788, Example M17 | (2S)-2-Amino-4-[{(1R)-1-...)
Affinity DataIC50: 4.17nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetKinesin-like protein KIF11(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM509105(US11071788, Example M18 | N-[2-({(2S)-2-Amino-4-[{...)
Affinity DataIC50: 5.17nMAssay Description:The motor domain of the human kinesin spindle protein KSP/Eg5 (tebu-bio/Cytoskeleton Inc, No. 027EG01-XL) was incubated in a concentration of 10 nM w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent